The Company also announced that it is actively negotiating a supply agreement for GMP IVT template with a mRNA therapeutic developer. Separately, the Company reaffirmed its intention to complete ...

The facility is undergoing final testing and is expected to be fully operational by the end of the current month. The Company also announced that it is actively negotiating a supply agreement for GMP ...